These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 1347812)

  • 21. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
    Senanayake P; Kramer DG
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD; Kessel E
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review.
    Steenland MW; Zapata LB; Brahmi D; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):611-24. PubMed ID: 23177264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic inflammatory disease and the intrauterine device: a causal relationship?
    Int J Gynaecol Obstet; 1980; 17(5):504-14. PubMed ID: 6103851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrauterine devices and pelvic inflammatory disease.
    McCarthy T; Roy AC; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):106-10. PubMed ID: 6388551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrauterine devices and pelvic inflammatory disease: evolving perspectives on the data.
    Burkman RT
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S35-41. PubMed ID: 8972501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intrauterine device, pelvic inflammatory disease, and infertility: the confusion between hypothesis and knowledge.
    Grimes DA
    Fertil Steril; 1992 Oct; 58(4):670-3. PubMed ID: 1426307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
    Kelly J; Aaron J
    Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.
    Weström L
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):880-92. PubMed ID: 7008604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraception and women's health.
    Fathalla MF
    Br Med Bull; 1993 Jan; 49(1):245-51. PubMed ID: 8324613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with today's IUDs.
    Pasquale S
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S25-9. PubMed ID: 8972499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.
    Tepper NK; Steenland MW; Gaffield ME; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):655-60. PubMed ID: 23040135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IUDs, inflammation, and infection: assessment after two decades of IUD use.
    Schmidt WA
    Hum Pathol; 1982 Oct; 13(10):878-81. PubMed ID: 6751984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial cultures from intrauterine devices removed from patients with pelvic inflammatory disease.
    Nilsson CG; Vartiainen E; Widholm O
    Acta Obstet Gynecol Scand; 1981; 60(6):563-6. PubMed ID: 7039215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper IUDs, PID, and fertility in nulliparous women.
    Struthers BJ
    Adv Contracept; 1991; 7(2-3):211-30. PubMed ID: 1950720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.